Try our Advanced Search for more refined results
Griffin Health Services Corporation et al v. Novo Nordisk Inc. et al
Case Number:
3:24-cv-01045
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Judge:
Firms
Companies
Sectors & Industries:
- 
						June 25, 2025
						Hospital Slams Novo Nordisk's Insulin Pen Suit Sanctions BidConnecticut's Griffin Hospital says Novo Nordisk's attempt to score sanctions in a lawsuit about insulin pen contamination should be rejected because no law requires the healthcare facility to lay out its adversary's possible defenses when pleading its claims. 
- 
						June 04, 2025
						Novo Nordisk Wants Hospital Sanctioned For Insulin Pen SuitNovo Nordisk Inc. has asked a Connecticut federal judge to sanction Griffin Health Services Corp. for suing the pharmaceutical company after settling a separate insulin pen contamination lawsuit, saying the hospital's complaint left out five important facts that could point blame back toward its own staff. 
- 
						April 15, 2025
						Novo Nordisk Seeks Toss Of Hospital's Insulin Pen SuitNovo Nordisk has told a Connecticut federal judge that a hospital in the state didn't show that the pharmaceutical company didn't warn nurses that its insulin pens are meant to be used with only one patient in a suit over a $1 million settlement the hospital paid to patients potentially exposed to blood-borne infections. 
- 
						February 11, 2025
						Novo Nordisk Mostly Escapes Insulin Pen Contamination SuitNovo Nordisk has, for now, beaten much of a Connecticut-based hospital's federal lawsuit seeking to hold it financially responsible for the $1 million settlement the hospital paid to patients potentially exposed to blood-borne infections after the medical staff used the pharma company's product. 
- 
						July 19, 2024
						Conn. Hospital Didn't Heed Insulin Pen Warnings, Maker SaysA Connecticut hospital "ignored" clear warnings from the manufacturer of insulin pens and federal regulators to avoid using the devices on multiple patients, leading to a $1 million class settlement, Novo Nordisk Inc. told a federal judge in urging the dismissal of a lawsuit against the pharma giant. 
- 
						July 17, 2024
						Hospital Trims Its Insulin Pen Claims Against Novo NordiskA Connecticut hospital and Novo Nordisk Inc. have agreed to dismiss several of the pharmaceutical giant's corporate entities from a suit seeking to make the company pay for the hospital's $1 million settlement from an underlying patient class action over allegedly defective insulin pens the firm made. 
- 
						June 04, 2024
						Insulin Pens Exposed Patients To Disease, Hospital SaysA Connecticut-based hospital says medical device manufacturer Novo Nordisk should be on the hook for a $1 million settlement the hospital paid to end claims that patients were exposed to blood-borne infections because of the medical staff's use of Novo Nordisk's product. 
